Search Results - Jimstan Periselneris

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The Effects of COVID-19 on Antifungal Prescribing in the UK—Lessons to Learn by Katharine Pates, Zhendan Shang, Rebeka Jabbar, Darius Armstrong-James, Silke Schelenz, Jimstan Periselneris, Rossella Arcucci, Anand Shah

    Published in Journal of Fungi (2024-11-01)
    Get full text
    Article


  2. 2

    Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study by Savvas Vlachos, Adrian Wong, Victoria Metaxa, Sergio Canestrini, Carmen Lopez Soto, Jimstan Periselneris, Kai Lee, Tanya Patrick, Christopher Stovin, Katrina Abernethy, Budoor Albudoor, Rishi Banerjee, Fatimah Juma, Sara Al-Hashimi, William Bernal, Ritesh Maharaj

    Published in Critical Care Research and Practice (2021-01-01)
    Get full text
    Article


  3. 3

    Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort. by Katie Bechman, Mark Yates, Kirsty Mann, Deepak Nagra, Laura-Jane Smith, Andy I Rutherford, Amit Patel, Jimstan Periselneris, David Walder, Richard J B Dobson, Zeljko Kraljevic, James H T Teo, William Bernal, Richard Barker, James B Galloway, Sam Norton

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  4. 4

    Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia by Rebecca F. D'Cruz, Michael D. Waller, Felicity Perrin, Jimstan Periselneris, Sam Norton, Laura-Jane Smith, Tanya Patrick, David Walder, Amadea Heitmann, Kai Lee, Rajiv Madula, William McNulty, Patricia Macedo, Rebecca Lyall, Geoffrey Warwick, James B. Galloway, Surinder S. Birring, Amit Patel, Irem Patel, Caroline J. Jolley

    Published in ERJ Open Research (2021-02-01)
    Get full text
    Article


  5. 5

    Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial by I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra M. Rzeszutek, Jack Pilgrim, Katie Bullock, Geoffrey Saunders, Josh Northey, Xiaofeng Dong, Yan Ryan, Helen Reynolds, Michelle Tetlow, Lauren E. Walker, Richard FitzGerald, Colin Hale, Rebecca Lyon, Christie Woods, Shazaad Ahmad, Dennis Hadjiyiannakis, Jimstan Periselneris, Emma Knox, Calley Middleton, Lara Lavelle-Langham, Victoria Shaw, William Greenhalf, Thomas Edwards, David G. Lalloo, Christopher J. Edwards, Alistair C. Darby, Miles W. Carroll, Gareth Griffiths, Saye H. Khoo, Julian A. Hiscox, Thomas Fletcher

    Published in Nature Communications (2022-11-01)
    Get full text
    Article


  6. 6

    Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report by Matthew S. Buckland, James B. Galloway, Caoimhe Nic Fhogartaigh, Luke Meredith, Nicholas M. Provine, Stuart Bloor, Ane Ogbe, Wioleta M. Zelek, Anna Smielewska, Anna Yakovleva, Tiffeney Mann, Laura Bergamaschi, Lorinda Turner, Frederica Mescia, Erik J. M. Toonen, Carl-Philipp Hackstein, Hossain Delowar Akther, Vinicius Adriano Vieira, Lourdes Ceron-Gutierrez, Jimstan Periselneris, Sorena Kiani-Alikhan, Sofia Grigoriadou, Devan Vaghela, Sara E. Lear, M. Estée Török, William L. Hamilton, Joanne Stockton, Josh Quick, Peter Nelson, Michael Hunter, Tanya I. Coulter, Lisa Devlin, CITIID-NIHR COVID-19 BioResource Collaboration, MRC-Toxicology Unit COVID-19 Consortium, John R. Bradley, Kenneth G. C. Smith, Willem H. Ouwehand, Lise Estcourt, Heli Harvala, David J. Roberts, Ian B. Wilkinson, Nick Screaton, Nicholas Loman, Rainer Doffinger, Paul A. Lyons, B. Paul Morgan, Ian G. Goodfellow, Paul Klenerman, Paul J. Lehner, Nicholas J. Matheson, James E. D. Thaventhiran

    Published in Nature Communications (2020-12-01)
    Get full text
    Article


Search Tools: